BioSpace News Archive

Quantum dot imaging advances

Luminescing nanosized crystals are showing promise for peering deeply into body tissues, but first they need to be made safe.

April 17, 2019
·
2 min read
The National Centre for Research and Development Awards Orion Biotechnology With a Grant to Progress Development of a Treatment for Advanced Colorectal Cancer

Orion Biotechnology Canada Ltd. announced that its European subsidiary Orion Biotechnology Polska Sp. z.o.o. was awarded a grant of just under two million U.S. dollars by the Polish National Centre for Research and Development (NCBR).

April 17, 2019
·
2 min read
Business

PureTech Health Inks Deal with Boehringer Ingelheim for Immuno-Oncology

PureTech, which has headquarters in Boston, but is listed in London, signed a research collaboration deal with Germany’s Boehringer Ingelheim. The companies will work to develop novel product candidates using PureTech’s proprietary lymphatic targeting technology for immune modulation.

April 17, 2019
·
3 min read
·
Mark Terry
Deals

Kiadis Will Marry Its T-Cell Platform to CytoSen’s NK-Cell Platform in All-Stock Deal

The combination of the two companies will create a leader in cell-based cancer immunotherapy, Kiadis said. It also further expands Kiadis’ toehold in the United States.

April 17, 2019
·
3 min read
·
Alex Keown
Drug Development

First U.S. Patients Are Treated With CRISPR as Echoes of Scandal in China Still Linger

The first clinical trials using CRISPR technology are expected to get underway in the United States, even as echoes of a scandal involving the use of CRISPR on embryos in China are still being felt across the globe.

April 17, 2019
·
2 min read
·
Alex Keown
Drug Development

MediciNova Announces Plans to Move Forward with a Phase 3 Trial of MN-166 (ibudilast) in ALS

MediciNova, Inc. announced that the U.S. Food and Drug Administration has completed its review of the protocol and determined that MediciNova may proceed with a Phase 2b/3 clinical trial of MN-166 in amyotrophic lateral sclerosis.

April 17, 2019
·
7 min read
Deals

BioArctic publishes the Annual Report for 2018

BioArctic AB announced that the Annual Report for the 2018 fiscal year has been published.

April 17, 2019
·
1 min read
FDA

Karolinska Development’s portfolio company Aprea Therapeutics has received FDA Orphan Drug Designation and Fast Track Designation for APR-246

Karolinska Development’s portfolio company Aprea Therapeutics has from FDA received an Orphan Drug Designation for APR-246 for the treatment of patients with Myelodysplastic Syndromes having a TP53 mutation.

April 17, 2019
·
3 min read
Business

Acting Commissioner Ned Sharpless Affirms Commitment to FDA’s Current Course

As Ned Sharpless takes over as acting commissioner of the U.S. Food and Drug Administration, he is not planning any disruptions or course corrections to the federal regulatory agency.

April 17, 2019
·
2 min read
·
Alex Keown
Bio NC

1Q2019 Life Science Growth Announcements

In the first quarter of 2019, more than 30 life science companies* announced expansions, new locations, increased funding, new trial and product launches and various other news pointing to a growing industry.

April 17, 2019
·
2 min read
·
Editorial Staff